z-logo
open-access-imgOpen Access
Weight Loss Improves β-Cell Function in People With Severe Obesity and Impaired Fasting Glucose: A Window of Opportunity
Author(s) -
Amy E. Rothberg,
William H. Herman,
Chun-Yi Wu,
Heidi B. IglayReger,
Jeffrey F. Horowitz,
Charles Burant,
Andrzej T. Gałecki,
Jeffrey B. Halter
Publication year - 2019
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/clinem/dgz189
Subject(s) - impaired fasting glucose , weight loss , medicine , type 2 diabetes , obesity , insulin resistance , body mass index , endocrinology , diabetes mellitus , insulin , impaired glucose tolerance
In people with obesity, β-cell function may adapt to insulin resistance. We describe β-cell function in people with severe obesity and normal fasting glucose (NFG), impaired fasting glucose (IFG), and type 2 diabetes (T2DM), as assessed before, 3 to 6 months after, and 2 years after medical weight loss to describe its effects on insulin sensitivity, insulin secretion, and β-cell function.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom